AMBOSS
AMBOSS is a medtech startup founded in Berlin in 2012 (launched in 2014) that offers a digital medical knowledge platform. It provides learning resources for medical students and evidence-based decision support for doctors, with up-to-date algorithms and clinical guidelines. In 2019 it raised โฌ30M in a Series B round, serving thousands of healthcare professionals worldwide to improve clinical decisions.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
About AMBOSS
AMBOSS is a digital medical knowledge platform founded in Berlin in 2012 and launched to market in 2014, born with the goal of making up-to-date medical knowledge accessible to all healthcare professionals. The product operates on two complementary levels: a continuously updated clinical reference library for practising physicians, and a study platform with thousands of exam questions for medical students. Both share the same underlying knowledge base but are optimised for different use cases. Its differentiation from printed textbooks and static online resources lies in hyperlinked structure and continuous updating: clinical guidelines are integrated directly into AMBOSS protocols, enabling physicians to consult them within seconds during patient consultations. In 2019, the company raised โฌ30 million in a Series B, accelerating international expansion and development of AI features for clinical decision support. AMBOSS today serves hundreds of thousands of physicians and medical students worldwide, with strong penetration in Germany, Austria, Switzerland, and the United States โ where it has established itself as a digital alternative to traditional resources like UpToDate.
Market & Clients
Geographic Presence
Funding & Investors
Total Funding
Similar Startups
EGYM
Intelligent fitness solutions and apps for gyms, enabling personalized workouts and member engagement.
Read AnalysisHepaRegeniX
Innovative regenerative medicine solutions aimed at curing liver disease and improving patient outcomes.
Read AnalysisINVITRIS
Biotechnology company focused on advancing research and development in life sciences and medical technology.
Read AnalysisSources
- AMBOSS โ official website — www.amboss.com